文献速递流行病学与生物统计新药、器械与细胞基因治疗研发

抗菌药物使用与耐药性

Antimicrobial use and resistance.
PubMed 文献 · BMJ · 2025-12-12

本文综述了近期政治行动、政策优先事项及未来威胁的识别,涉及耐药病原体所致感染及可能满足未满足医疗需求的现有和新型抗菌药物。尽管政治参与增加,全球抗菌药物耐药格局仍不均衡:高收入医院环境的诊断、抗菌药物管理和感染防控在改善,而中低收入国家获取这些进展有限。在所有环境中,经验性处方基本抗菌药物仍是治疗基石,保护其疗效至关重要。

要点

  • 2024年联合国大会高级别会议明确承诺降低死亡率和改善抗生素使用。
  • 高收入医院环境中诊断、抗菌药物管理和感染防控正在改善,可能受益于人工智能和信息系统。
  • 中低收入国家获取大多数进展有限,经验性处方基本抗菌药物仍是所有环境中治疗的基石。

核心结论

  • 尽管政治参与增加,全球抗菌药物耐药格局仍不均衡,需要针对性预防和最佳治疗策略以减轻所有环境中的抗菌药物耐药。

研究设计与样本

  • 本文为综述,总结近期政治行动、政策优先事项及未来威胁的识别,并审视耐药病原体所致感染及现有和新型抗菌药物。

主要发现

  • 高收入医院环境中诊断、抗菌药物管理和感染防控正在改善,可能进一步受益于人工智能和信息系统。
  • 中低收入国家获取大多数进展有限。
  • 在所有环境中,经验性处方基本抗菌药物仍是治疗基石,保护其疗效对有效医疗至关重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial resistance affects the delivery of safe and effective healthcare. Antimicrobial resistance has attracted strong political focus, with the 2024 United Nations General Assembly high level meeting providing a clear commitment to reducing mortality and improving antibiotic use. This review summarises recent political action, policy prioritisation, and identification of future threats. It considers infections that are caused by drug resistant pathogens and reviews available and new antibiotics that may meet unmet medical needs. Despite increasing political engagement, the global antimicrobial resistance landscape remains imbalanced. In high income hospital settings, diagnostics, antimicrobial stewardship, and infection prevention and control are improving and may be further enabled by artificial intelligence and information systems. The development and use of new antibiotics is a major focus. By contrast, in low and middle income countries, access to most of these advances is limited. In all settings, empirical prescribing of essential antibiotics remains the cornerstone of treatment and conserving their efficacy is critical to effective healthcare. Targeted prevention and optimal treatment strategies are needed to mitigate antimicrobial resistance across all settings.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Reza N, Dubey V, Sharland M, et al. Antimicrobial use and resistance. BMJ. 2025. PMID: 41386779. doi:10.1136/bmj-2024-082681

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。